InvestorsHub Logo
icon url

InternetForumUser

10/13/14 1:00 PM

#193436 RE: BioBS2012 #193431

YES, they are - to ME. Hopefully some day to you.

No matter what my view is of the BOD.. I will still keep 10,000 shares and let it ride.. just to see what happens; however, I will sell most of my shares during the next spike (If it happens). My best guess, is that there will be a run up some time in January, February or March of 2015.

Either way.. Good luck to you and everyone else...
icon url

shipbuilder

10/13/14 2:24 PM

#193459 RE: BioBS2012 #193431

I don't buy the argument that Peregrine should, or that it is, totally focused on Bavituximab's cancer indications. The company employs around 180 individuals, each one available to team up and execute on their applicable skill set.


If Bavituximab is particularly effective on Ebola, HIV, or a dozen other viruses then work done is those areas hardly qualifies as a distraction.

I am impressed with the quality and quantity of Peregrine management's achievements. I am distressed by Peregrine's treatment of its shareholders. Shareholders work hard for our money, so hard for it honey. We work hard for our money so you better treat us right.


PPHM, THE COMPANY THAT'S LIKE KALE. IMHO